Trust Worldwide to Guide Your Macular Edema Intervention Through Clinical Trials

Macular edema can cause visual distortions, such as fuzziness or waviness in the center of one’s field of vision. It’s caused by a buildup of fluid in the macula, the light-sensitive portion of the retina. Sometimes, that fluid buildup is a result of leakage from weakened blood vessels in the retina (which often happens in people with diabetic retinopathy); other times, it occurs after eye surgery or in conjunction with “wet” macular degeneration, where new blood vessels grow into the macula and leak fluids.

Once diagnosed, macular edema can be managed with novel medicines, corticosteroids, or nonsteroidal anti-inflammatory drugs (NSAIDs). Yet, each of these methods has drawbacks and potential side effects. If you’re working on ways to prevent or better manage macular edema, you’ll need to prove the safety and effectiveness of your approach before you can offer it to the millions of people who could benefit.

That’s where Worldwide Clinical Trials can help. With more than 30 years of experience, Worldwide is recognized around the world as the expert in clinical trial management. We offer full-service support for Phase I-Phase IV clinical trials. We also offer real-world evidence studies that can help you understand both the short- and long-term effects of your therapy.

Are you ready to bring your macular edema therapy to the next level? Contact Worldwide.